SGX Pharmaceuticals, Inc.
Records under this name other than patents SGX Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to SGX Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,071,581 | Triazolopyridazine protein kinase modulators Lapsed on the fee record Ended Dec 6, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 6, 2019 | From the USPTO record |
| US 7,829,558 | Fused ring heterocycle kinase modulators Lapsed on the fee record Ended Nov 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2018 | From the USPTO record |
| US 7,709,645 | Pyrrolo-pyridine kinase modulators Lapsed on the fee record Ended May 4, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2018 | From the USPTO record |
| US 7,626,021 | Fused ring heterocycle kinase modulators Lapsed on the fee record Ended Dec 1, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 1, 2017 | From the USPTO record |
| US 7,601,839 | Pyrrolo-pyridine kinase modulators Lapsed on the fee record Ended Oct 13, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 13, 2017 | From the USPTO record |
| US 7,582,637 | Pyrrolo-pyridine kinase modulators Lapsed on the fee record Ended Sep 1, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 1, 2017 | From the USPTO record |
| US 8,507,489 | Bicyclic triazoles as protein kinase modulators Lapsed on the fee record Ended Aug 13, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2017 | From the USPTO record |
| US 7,452,993 | Fused ring heterocycle kinase modulators Lapsed on the fee record Ended Nov 18, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2016 | From the USPTO record |
| US 8,268,994 | Fused ring heterocycle kinase modulators Lapsed on the fee record Ended Sep 18, 2016 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2016 | From the USPTO record |
| US 8,242,280 | Fused ring heterocycle kinase modulators Lapsed on the fee record Ended Aug 14, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2016 | From the USPTO record |